{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:28:57Z","timestamp":1648992537577},"reference-count":0,"publisher":"Akademiai Kiado Zrt.","issue":"48","license":[{"start":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T00:00:00Z","timestamp":1606608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2020,11,29]]},"abstract":"\u00d6sszefoglal\u00f3.<\/jats:bold>\n Bevezet\u00e9s:<\/jats:italic> Csecsem\u0151korban a k\u00f6nnyez\u00e9s gyakori oka a\n k\u00f6nnycsatorna velesz\u00fcletett elz\u00e1r\u00f3d\u00e1sa, mely az esetek nagy r\u00e9sz\u00e9ben 1 \u00e9ves\n korra spont\u00e1n old\u00f3dik. C\u00e9lkit\u0171z\u00e9s:<\/jats:italic> Retrospekt\u00edv tanulm\u00e1nyunk\n c\u00e9lja a monocanalicularis szilikonsztent (Masterka\u00ae<\/jats:sup>) implant\u00e1ci\u00f3j\u00e1val\n kapcsolatos eredm\u00e9nyeink bemutat\u00e1sa. M\u00f3dszer:<\/jats:italic> 2015. janu\u00e1r 1.\n \u00e9s 2020. janu\u00e1r 30. k\u00f6z\u00f6tt monocanalicularis szilikonsztent implant\u00e1ci\u00f3j\u00e1n\n \u00e1tesett gyermekek adatait dolgoztuk fel. Bevon\u00e1si krit\u00e9riumk\u00e9nt szerepelt a\n legal\u00e1bb 6 h\u00f3napja fenn\u00e1ll\u00f3, konzervat\u00edv kezel\u00e9sre nem sz\u0171n\u0151 k\u00f6nnyez\u00e9s \u00e9s emiatt\n el\u0151zetesen elv\u00e9gzett szond\u00e1z\u00e1s, mely ut\u00e1n a panaszok ki\u00fajultak. Kiz\u00e1r\u00e1si\n krit\u00e9rium volt a csontosan elz\u00e1rt ductus nasolacrimalis \u00e9s a hib\u00e1s szemh\u00e9j\u00e1ll\u00e1s.\n A m\u0171t\u00e9t hat\u00e9konys\u00e1g\u00e1t a szilikonsztent elt\u00e1vol\u00edt\u00e1s\u00e1t k\u00f6vet\u0151 legal\u00e1bb 2 h\u00f3nap\n panaszmentess\u00e9ggel defini\u00e1ltuk. Eredm\u00e9nyek:<\/jats:italic> 25 gyermek (10 l\u00e1ny\n [40%] \u00e9s 15 fi\u00fa [60%]) \u00f6sszesen 30 szem\u00e9n v\u00e9gezt\u00fcnk szilikonsztent-be\u00fcltet\u00e9st.\n Az \u00e1tlag\u00e9letkor 4,92 \u00b1 3,03 \u00e9v (1,5\u201312 \u00e9v, n = 25) volt. Minden p\u00e1ciens a\n sz\u00fclet\u00e9se \u00f3ta k\u00f6nnyezett. A m\u0171t\u00e9t el\u0151tt v\u00e1lad\u00e9kk\u00e9pz\u0151d\u00e9st 20 (66,67%, n = 30),\n kr\u00f3nikus szemh\u00e9j- \u00e9s k\u00f6t\u0151h\u00e1rtya-gyullad\u00e1st 10 (33,33%, n = 30) esetben\n \u00e9szlelt\u00fcnk. Tompal\u00e1t\u00e1st, jelent\u0151s astigmi\u00e1t nem tal\u00e1ltunk. A sztentet \u00e1tlagosan\n 3,5 \u00b1 1,0 (n = 30) h\u00f3nap ut\u00e1n t\u00e1vol\u00edtottuk el. A m\u0171t\u00e9tet k\u00f6vet\u0151en 1 h\u00e9ttel 24\n (80%, n = 30), 3 h\u00f3nappal 28 (93,33%, n = 30) \u00e9s 6 h\u00f3nappal 24 (88,89%, n = 27)\n szem volt t\u00fcnetmentes. K\u00f6vetkeztet\u00e9s:<\/jats:italic> A Masterka\u00ae<\/jats:sup>\n implant\u00e1ci\u00f3ja egyszer\u0171en kivitelezhet\u0151, kifejezetten hat\u00e9kony m\u00f3dszer lehet az 1\n \u00e9vn\u00e9l id\u0151sebb gyermekek velesz\u00fcletett k\u00f6nnycsatorna-sz\u0171k\u00fclet\u00e9nek megold\u00e1s\u00e1ra,\n k\u00fcl\u00f6n\u00f6sen olyan esetekben, amikor a kor\u00e1bbi szond\u00e1z\u00e1s nem vezetett eredm\u00e9nyre,\n valamint hosszabb szakaszon \u00e9szlel\u00fcnk sz\u0171k\u00fcletet. Ez ut\u00f3bbi esetekben\n megfontoland\u00f3 lenne a primer szilikonsztent-implant\u00e1ci\u00f3 is. Orv Hetil. 2020;\n 161(48): 2037\u20132042.<\/jats:p>\n Summary.<\/jats:bold>\n Introduction:<\/jats:italic> Congenital nasolacrimal duct obstruction is a\n common cause of epiphora in infants. In most cases, spontaneous resolution\n occurs by 1 year of age. Objective:<\/jats:italic> Retrospective evaluation of\n clinical outcomes of monocanalicular lacrimal duct stent implantation\n (Masterka\u00ae<\/jats:sup>). Method:<\/jats:italic> Data of patients undergoing\n monocanalicular silicone stent implantation between 1st January 2015 and 30th\n January 2020 were evaluated. Inclusion criteria were resistant tearing to\n conservative therapy which had been persisting at least for 6 months, and\n previous probing did not resolve the symptoms. Exclusion criteria were\n associated bony obstruction or eyelid malposition. Treatment success was defined\n as complete resolution of epiphora at least two months after the procedure.\n Results:<\/jats:italic> Implantation was performed on 30 eyes of 25\n children (10 females [40%] and 15 males [60%]). The mean age was 4.92 \u00b1 3.03\n years (1.5\u201312 years, n = 25). Epiphora was a persistent symptom in every patient\n since birth. Preoperatively, discharge was observed in 20 (66.6%, n = 30)\n patients, while chronic blepharitis and conjunctivitis occurred in 10 (33.33%, n\n = 30) children. Amblyopia or significant astigmatism was not observed in any\n case. Stent was removed after 3.5 \u00b1 1.0 (n = 30) months. At one week\n postoperatively 24 (80%, n = 30), at 3 months 28 (93.33%, n = 30) and at 6\n months 24 (88.89%, n = 27) eyes were asymptomatic. Conclusion:<\/jats:italic>\n Implantation of monocanalicular silicone stent is effective and easy-to-perform.\n It can resolve congenital tear duct stenosis, especially where previous probing\n was not successful and where stenosis is longer or occurs in several\n localizations. In the latter cases, primary stent implantation should be\n considered. Orv Hetil. 2020; 161(48): 2037\u20132042.<\/jats:p>","DOI":"10.1556\/650.2020.31906","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T01:07:46Z","timestamp":1606871266000},"page":"2037-2042","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":0,"title":["Monocanalicularis szilikonsztent implant\u00e1ci\u00f3ja k\u00f6nnycsatorna-elz\u00e1r\u00f3d\u00e1ssal sz\u00fcletett gyermekekben"],"prefix":"10.1556","volume":"161","author":[{"given":"Ir\u00e9n","family":"Szalai","sequence":"first","affiliation":[{"name":"1 \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika, Semmelweis Egyetem, Budapest, M\u00e1ria u. 39., 1085"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto Alexander","family":"Maneschg","sequence":"additional","affiliation":[{"name":"1 \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika, Semmelweis Egyetem, Budapest, M\u00e1ria u. 39., 1085"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"additional","affiliation":[{"name":"1 \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika, Semmelweis Egyetem, Budapest, M\u00e1ria u. 39., 1085"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/161\/48\/article-p2037.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/161\/48\/article-p2037.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T01:12:54Z","timestamp":1633914774000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/161\/48\/article-p2037.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,29]]},"references-count":0,"journal-issue":{"issue":"48"},"URL":"https:\/\/doi.org\/10.1556\/650.2020.31906","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,29]]}}}